METHOD OF TREATMENT

摘要

The present invention relates to recombinant human bile-salt-stimulated lipase (rhBSSL) for use in treatment of a human infant either risking growth restriction or neurodevelopmental delay. The treatment comprises enteral administration of rhBSSL to said infant for a time period of at least around four weeks to improve growth of said infant. Moreover, rhBSSL for use in treatment of human infants being small for their gestational age is also disclosed.